267 related articles for article (PubMed ID: 29344870)
1. Cell-Specific RNA Quantification in Human SN DA Neurons from Heterogeneous Post-mortem Midbrain Samples by UV-Laser Microdissection and RT-qPCR.
Duda J; Fauler M; Gründemann J; Liss B
Methods Mol Biol; 2018; 1723():335-360. PubMed ID: 29344870
[TBL] [Abstract][Full Text] [Related]
2. Orchestrated increase of dopamine and PARK mRNAs but not miR-133b in dopamine neurons in Parkinson's disease.
Schlaudraff F; Gründemann J; Fauler M; Dragicevic E; Hardy J; Liss B
Neurobiol Aging; 2014 Oct; 35(10):2302-15. PubMed ID: 24742361
[TBL] [Abstract][Full Text] [Related]
3. Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease.
Gründemann J; Schlaudraff F; Haeckel O; Liss B
Nucleic Acids Res; 2008 Apr; 36(7):e38. PubMed ID: 18332041
[TBL] [Abstract][Full Text] [Related]
4. UV-laser microdissection and mRNA expression analysis of individual neurons from postmortem Parkinson's disease brains.
Gründemann J; Schlaudraff F; Liss B
Methods Mol Biol; 2011; 755():363-74. PubMed ID: 21761319
[TBL] [Abstract][Full Text] [Related]
5. Meta-Analysis of Parkinson's Disease Transcriptome Data Using TRAM Software: Whole Substantia Nigra Tissue and Single Dopamine Neuron Differential Gene Expression.
Mariani E; Frabetti F; Tarozzi A; Pelleri MC; Pizzetti F; Casadei R
PLoS One; 2016; 11(9):e0161567. PubMed ID: 27611585
[TBL] [Abstract][Full Text] [Related]
6. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.
Duda J; Pötschke C; Liss B
J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):156-178. PubMed ID: 26865375
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology.
Simunovic F; Yi M; Wang Y; Macey L; Brown LT; Krichevsky AM; Andersen SL; Stephens RM; Benes FM; Sonntag KC
Brain; 2009 Jul; 132(Pt 7):1795-809. PubMed ID: 19052140
[TBL] [Abstract][Full Text] [Related]
8. Regional vulnerability of mesencephalic dopaminergic neurons prone to degenerate in Parkinson's disease: a post-mortem study in human control subjects.
Lu L; Neff F; Fischer DA; Henze C; Hirsch EC; Oertel WH; Schlegel J; Hartmann A
Neurobiol Dis; 2006 Aug; 23(2):409-21. PubMed ID: 16753304
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
10. Multiomic Analyses of Dopaminergic Neurons Isolated from Human Substantia Nigra in Parkinson's Disease: A Descriptive and Exploratory Study.
Zaccaria A; Antinori P; Licker V; Kövari E; Lobrinus JA; Burkhard PR
Cell Mol Neurobiol; 2022 Nov; 42(8):2805-2818. PubMed ID: 34528139
[TBL] [Abstract][Full Text] [Related]
11. NCS-1 Deficiency Affects mRNA Levels of Genes Involved in Regulation of ATP Synthesis and Mitochondrial Stress in Highly Vulnerable
Simons C; Benkert J; Deuter N; Poetschke C; Pongs O; Schneider T; Duda J; Liss B
Front Mol Neurosci; 2019; 12():252. PubMed ID: 31827421
[TBL] [Abstract][Full Text] [Related]
12. Compensatory T-type Ca2+ channel activity alters D2-autoreceptor responses of Substantia nigra dopamine neurons from Cav1.3 L-type Ca2+ channel KO mice.
Poetschke C; Dragicevic E; Duda J; Benkert J; Dougalis A; DeZio R; Snutch TP; Striessnig J; Liss B
Sci Rep; 2015 Sep; 5():13688. PubMed ID: 26381090
[TBL] [Abstract][Full Text] [Related]
13. Isolation of Distinct Types of Neurons from Fresh Brain Tissue Using Laser Microdissection in Combination with High-Performance Liquid Chromatography-Mass Spectrometry.
Aring L; Steinbach S; Marcus K; May C
Methods Mol Biol; 2018; 1723():247-260. PubMed ID: 29344865
[TBL] [Abstract][Full Text] [Related]
14. Gene expression patterns for GDNF and its receptors in the human putamen affected by Parkinson's disease: a real-time PCR study.
Bäckman CM; Shan L; Zhang YJ; Hoffer BJ; Leonard S; Troncoso JC; Vonsatel P; Tomac AC
Mol Cell Endocrinol; 2006 Jun; 252(1-2):160-6. PubMed ID: 16644101
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
16. Effect of siRNA-induced silencing of cellular prion protein on tyrosine hydroxylase expression in the substantia nigra of a rat model of Parkinson's disease.
Wang X; Yang HA; Wang XN; Du YF
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173342
[TBL] [Abstract][Full Text] [Related]
17. Isoforms of the Erythropoietin receptor in dopaminergic neurons of the Substantia Nigra.
Marcuzzi F; Zucchelli S; Bertuzzi M; Santoro C; Tell G; Carninci P; Gustincich S
J Neurochem; 2016 Nov; 139(4):596-609. PubMed ID: 27488413
[TBL] [Abstract][Full Text] [Related]
18. Midbrain dopamine neurons in Parkinson's disease exhibit a dysregulated miRNA and target-gene network.
Briggs CE; Wang Y; Kong B; Woo TU; Iyer LK; Sonntag KC
Brain Res; 2015 Aug; 1618():111-21. PubMed ID: 26047984
[TBL] [Abstract][Full Text] [Related]
19. Laser capture microdissection protocol for gene expression analysis in the brain.
Garrido-Gil P; Fernandez-Rodríguez P; Rodríguez-Pallares J; Labandeira-Garcia JL
Histochem Cell Biol; 2017 Sep; 148(3):299-311. PubMed ID: 28560490
[TBL] [Abstract][Full Text] [Related]
20. Combining laser microdissection and microRNA expression profiling to unmask microRNA signatures in complex tissues.
Skalicky S; Zwiers PJ; Kuiper T; Schraml E; Hackl M; Molema G
Biotechniques; 2019 Dec; 67(6):276-285. PubMed ID: 31621384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
